|

Heparin vs Placebo for Cardiac Catheterization

RECRUITINGPhase 3Sponsored by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Actively Recruiting
PhasePhase 3
SponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Started2020-10-05
Est. completion2026-08
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04374799

Summary

Patients undergoing cardiac catheterization will be randomized to 3 groups: no anticoagulant, low dose anticoagulant and high dose anticoagulant.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* diagnostic cardiac catheterization; Small size sheath; patency of the ulno-palmar circulation

Exclusion Criteria:

abnormal ulno-palmar circulation; Prior radial artery thrombosis; Prior surgery close to the access site; Emergent cardiac catheterization; History of HIT or allergy to heparin; Patients requiring anticoagulation

Conditions2

Cardiac DiseaseHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.